VXRT – vaxart, inc. (US:NASDAQ)
Stock Stats
News
11/19
08:00 am
vxrt
Low
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/13
04:01 pm
vxrt
High
Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results
11/7
08:00 am
vxrt
Low
Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13
10/24
08:00 am
vxrt
Low
Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024
10/15
08:00 am
vxrt
Low
Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need
11/13/2024
04:01 pm
VXRT
-11.9%
BEAT
8/8/2024
04:01 pm
VXRT
-9.4%
MISS
5/13/2024
04:01 pm
VXRT
5.4%
BEAT
11/13
04:24 pm
vxrt
High
Form 10-Q Vaxart, Inc. For: Sep 30
11/13
04:06 pm
vxrt
High
Form 8-K Vaxart, Inc. For: Nov 13
10/8
04:06 pm
vxrt
Medium
Form 424B5 Vaxart, Inc.
10/8
04:06 pm
vxrt
Low
Form 8-K Vaxart, Inc. For: Oct 08
9/30
05:20 pm
vxrt
Medium
Form 8-K Vaxart, Inc. For: Sep 27
Show more
Top News Gainers
1/31 Vaxart Announces Initiation of Coronavirus Vaccine Program 43.7%
2/26 Vaxart Inc (NASDAQ: VXRT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 31.2%
4/24 Form DEFA14A Vaxart, Inc. 20.0%
8/8 Q2/2019 6/30/2019 EPS -0.390 ZacksConsensus -0.500 ActVsEst 0.110 - Beat 19.0%
9/27 Form POS AM Vaxart, Inc. 18.6%
4/14 Form 8-K Vaxart, Inc. For: Apr 13 15.3%
2/1 Vaxart Inc (NASDAQ: VXRT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 14.4%
1/22 Results from Influenza Challenge Study Published in Lancet Infectious Diseases 13.4%
11/22 Form SC 13D/A Vaxart, Inc. Filed by: ARMISTICE CAPITAL, LLC 11.8%
4/21 Thinking about buying stock in Carnival Corp, MGM Resorts, Teekay Tankers, Uber, or Vaxart? 10.9%
Top News Decliners
9/25 Vaxart’s Tableted Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b Study -49.1%
4/30 Vaxart Inc (NASDAQ: VXRT) had its price target raised by analysts at HC Wainwright from $3.00 to $7.00. -22.0%
3/19 Vaxart Inc (NASDAQ: VXRT) had its "buy" rating re-affirmed by analysts at HC Wainwright. -17.9%
9/11 Form S-1 Vaxart, Inc. -15.1%
4/28 Vaxart Announces Corporate Update for First Quarter 2020 -13.9%
9/26 Vaxart Announces Pricing of $8 Million Underwritten Public Offering -13.2%
3/19 Form 8-K Vaxart, Inc. For: Mar 18 -12.2%
3/18 IMV up 53% premarket on coronavirus vaccine plan [Seeking Alpha] -9.7%
2/11 Form SC 13G/A Vaxart, Inc. Filed by: BML Investment Partners, L.P. -8.5%
4/29 Form 8-K Vaxart, Inc. For: Apr 28 -8.3%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3